Fk 506 and Autoimmune Disease: Perspective and Prospects
- 1 January 1992
- journal article
- review article
- Published by Taylor & Francis in Autoimmunity
- Vol. 12 (4), 303-313
- https://doi.org/10.3109/08916939209148473
Abstract
(1992). Fk 506 and Autoimmune Disease: Perspective and Prospects. Autoimmunity: Vol. 12, No. 4, pp. 303-313.Keywords
This publication has 62 references indexed in Scilit:
- Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexesCell, 1991
- PRECLINICAL EVALUATION OF A NEW POTENT IMMUNOSUPPRESSIVE AGENT, RAPAMYCINTransplantation, 1991
- Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A?The Journal of Experimental Medicine, 1991
- The effects of a new immunosuppressive agent, FK506, on the glomerular injury in rats with accelerated nephrotoxic serum glomerulonephritisClinical Immunology and Immunopathology, 1990
- Prevention of spontaneous diabetes in BB rats with FK 506The Lancet, 1990
- A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilinNature, 1989
- Effect of FK-506, a novel immunosuppressive drug on murine systemic lupus erythematosusClinical Immunology and Immunopathology, 1989
- FK-506 — How much potential?Immunology Today, 1989
- Immunosuppressive effect of FK506 on collagen-induced arthritis in ratsClinical Immunology and Immunopathology, 1988
- Immunosuppressive effect of FK506 on experimental allergic encephalomyelitis in ratsInternational Journal of Immunopharmacology, 1988